Faeth Therapeutics CEO gifts 100,000 shares to trust

Faeth Therapeutics, Inc. (FTH) President and CEO Anand Kiran Parikh reported a gift transfer of 100,000 common shares to the AKP Irrevocable Trust on October 30, 2026, for the benefit of his immediate family members.

Available on EDGAR 11/03/2026 - 08:33 PM EST Accepted by SEC EDGAR 11/03/2026 - 08:33 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Faeth Therapeutics, Inc. (FTH) President and CEO Anand Kiran Parikh reported a gift transfer of 100,000 common shares to the AKP Irrevocable Trust on October 30, 2026, for the benefit of his immediate family members. After the transfer, Parikh directly held 717,699 shares, and the trust held 100,000 shares of record. Parikh serves as the trust’s investment advisor with authority to direct its trustee and disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary

200,000 shares gifted

Gift 2 txns

Insider Parikh Anand Kiran

Role President and CEO

Type	Security	Shares	Price	Value
Gift	Common Stock F1	100,000	$0.00	$0.00
Gift	Common Stock F1, F2	100,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 717,699 shares (Direct); Common Stock — 100,000 shares (Indirect, See footnote)

Footnotes (2)

1. F1. Represents the number of the shares of the Issuer's Common Stock gifted to AKP Irrevocable Trust for the benefit of the Reporting Person's immediate family members.
2. F2. The shares are held of record by the AKP Irrevocable Trust, of which the Reporting Person's immediate family members are the beneficiaries. Preservation Trust Company serves as trustee, and the Reporting Person serves as investment advisor with authority to direct the trustee on the investment of trust assets. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Key Figures

Shares gifted: 100,000 shares Direct shares following transfer: 717,699 shares Trust shares held of record: 100,000 shares

3 metrics

Shares gifted 100,000 shares Gift transfer to the AKP Irrevocable Trust on October 30, 2026

Direct shares following transfer 717,699 shares Anand Kiran Parikh's reported direct holdings after the October 30, 2026 transfer

Trust shares held of record 100,000 shares AKP Irrevocable Trust after the October 30, 2026 gift transfer

Key Terms

held of record, beneficial ownership, pecuniary interest

3 terms

held of record financial

"The shares are held of record by the AKP Irrevocable Trust"

beneficial ownership regulatory

"disclaims beneficial ownership of the shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FTH shares were gifted to the AKP Irrevocable Trust?

Anand Kiran Parikh reported a gift transfer of 100,000 FTH common shares to the AKP Irrevocable Trust on October 30, 2026, for the benefit of his immediate family members.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Parikh Anand Kiran

(Last) (First) (Middle)

C/O FAETH THERAPEUTICS, INC.

701 TILLERY STREET #12 #1010

(Street)

AUSTIN TEXAS 78702

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Faeth Therapeutics, Inc. [ FTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/30/2026		G		100,000(1)	D	$0	717,699	D
Common Stock	10/30/2026		G		100,000(1)	A	$0	100,000	I	See footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the number of the shares of the Issuer's Common Stock gifted to AKP Irrevocable Trust for the benefit of the Reporting Person's immediate family members.

2. The shares are held of record by the AKP Irrevocable Trust, of which the Reporting Person's immediate family members are the beneficiaries. Preservation Trust Company serves as trustee, and the Reporting Person serves as investment advisor with authority to direct the trustee on the investment of trust assets. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

	/s/ Josiah Craver, Attorney-in-Fact	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)